A Look At Elevance Health (ELV) Valuation After Earnings Beat And Higher EPS Guidance

Simply Wall St.06-11

Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2642947382?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160","is_english":true,"pubTime":"2026-06-11 01:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2642947382","market":"nz","top_or_hot":-1,"title":"A Look At Elevance Health (ELV) Valuation After Earnings Beat And Higher EPS Guidance","media":"Simply Wall St.","content":"<div>\n<p>Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat-1\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Elevance Health (ELV) Valuation After Earnings Beat And Higher EPS Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Elevance Health (ELV) Valuation After Earnings Beat And Higher EPS Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-06-11 01:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat-1><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat-1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ELV.AU","symbol_name":"ELEVRA LITHIUM LTD","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat-1","article_id":"2642947382","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/company-cover/160077-main-header/1756254056160"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-elv/elevance-health/news/a-look-at-elevance-health-elv-valuation-after-earnings-beat-1","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2642947382","pubTimestamp":1781112260,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare Advantage payment rates.\nSee our latest analysis for Elevance Health.\nThe recent earnings beat and higher 2026 EPS guidance have coincided with strong momentum, with Elevance Health’s 90 day share price return of 46.46% and a 1 year total shareholder return of 12.87% suggesting sentiment has...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"ELV.AU":"ELEVRA LITHIUM LTD","ELV":"Elevance Health"},"translate_title":"盈利超出预期和每股收益指引上调后Elevance Health(ELV)估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ELV":1.5,"ELV.AU":1.5},"content_text":"Elevance Health (ELV) is back in focus after reporting Q1 revenue and earnings above analyst expectations and lifting full year 2026 adjusted EPS guidance, following higher than expected 2027 Medicare Advantage payment rates. See our latest analysis for Elevance Health. The recent earnings beat and higher 2026 EPS guidance have coincided with strong momentum, with Elevance Health’s 90 day share price return of 46.46% and a 1 year total shareholder return of 12.87% suggesting sentiment has improved after a softer 3 year total shareholder return, which declined 4.87%. If Elevance Health’s recent move has you looking beyond large insurers, this could be a good moment to scan the market for other resilient businesses via the 20 top founder-led companies With Elevance Health now trading close to analyst price targets, yet flagged as a value pick and showing an intrinsic discount of about 60%, the key question is whether there is still an opportunity here or if the market is already pricing in future growth. AdvertisementMost Popular Narrative: 9.4% Overvalued The most followed valuation narrative currently puts Elevance Health's fair value at $387.85, which sits below the last close of $424.43, highlighting a gap investors may want to understand.  Strategic investments in digital consumer engagement and Carelon's diversified health services (e.g., pharmacy, care management, behavioral health) are accelerating revenue growth and providing higher-margin, recurring income streams, which should drive both topline and earnings diversity as industry healthcare spending and complexity continue to rise.  Read the complete narrative. Curious what assumptions sit behind that fair value gap, the projected revenue step up, margin rebuild, and the earnings multiple that ties it all together. Result: Fair Value of $387.85 (OVERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, there is still meaningful policy and cost risk here, particularly if elevated medical utilization persists or if Medicaid and ACA rate adjustments lag underlying claims trends. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other companies tied to the new space race are already in orbit. → 20 Compelling Space Companies watchlist · Global Space Race Investing Ideas screener · Scan the sector by valuation on Rocket Lab's valuation page. Another View: Valuation Gap on Earnings The DCF output points to Elevance Health trading well below an estimated future cash flow value of $1,050.72, which contrasts sharply with the narrative fair value of $387.85 and the current price of $424.43. That gap raises a simple question: is the market too cautious about long term cash generation, or are the DCF inputs too generous? Look into how the SWS DCF model arrives at its fair value. ELV Discounted Cash Flow as at Jun 2026Next Steps If the mixed messages in the numbers leave you unsure, that is the point. Now is the time to look through the data yourself and weigh the 4 key rewards. Looking for more investment ideas? If Elevance Health sharpened your focus, do not stop here. Use the Simply Wall St screener to hunt for other stocks that fit your style and goals.  Target stability and consistency by scanning companies with strong financial footing through the solid balance sheet and fundamentals stocks screener (46 results) Hunt for potential bargains by filtering companies that combine quality fundamentals with attractive pricing using the 46 high quality undervalued stocks Spot early opportunities by tracking smaller companies with resilient metrics inside the 24 elite penny stocks with strong financials   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n        and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n        financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n        Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n        Simply Wall St has no position in any stocks mentioned.Valuation is complex, but we're here to simplify it.Discover if Elevance Health might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"dataReport","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2642947382","isCrawlerRequest":true}